Mammalian Target of Rapamycin (mTOR) Activity Dependent Phospho-Protein Expression in Childhood Acute Lymphoblastic Leukemia (ALL)

Modern treatment strategies have improved the prognosis of childhood ALL; however, treatment still fails in 25–30% of patients. Further improvement of treatment may depend on the development of targeted therapies. mTOR kinase, a central mediator of several signaling pathways, has recently attracted...

Descripción completa

Detalles Bibliográficos
Autores principales: Nemes, Karolina, Sebestyén, Anna, Márk, Ágnes, Hajdu, Melinda, Kenessey, István, Sticz, Tamás, Nagy, Eszter, Barna, Gábor, Váradi, Zsófia, Kovács, Gábor, Kopper, László, Csóka, Monika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616065/
https://www.ncbi.nlm.nih.gov/pubmed/23573198
http://dx.doi.org/10.1371/journal.pone.0059335

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3616065/
https://www.ncbi.nlm.nih.gov/pubmed/23573198
http://dx.doi.org/10.1371/journal.pone.0059335

Ejemplares similares